Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapies for treatment resistant cancers. Its approach targets ferroptosis, an anti-cancer mechanism resulting in iron-mediated cancer cell death. Hillstream BioPharma was incorporated in 2017 and is based in Bridgewater, NJ.
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $920.69 | A | |
| $16.97 | A | |
| $13.09 | A |